Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial
Provided By PR Newswire
Last update: Aug 25, 2025
The NEPHRO CRRT pivotal trial has now reached approximately 25% enrollment, driven by the recent acceleration in the recruitment rate from new profile clinical sites
Read more at prnewswire.comNASDAQ:TLPH (9/30/2025, 8:00:01 PM)
0.8932
-0.02 (-1.85%)
Find more stocks in the Stock Screener
